This research develops nanobubble-enhanced ultrasound imaging as an accessible alternative to MRI for cancer diagnosis. Tiny gas-filled nanoparticles amplify ultrasound signals and improve image quality, particularly in prostate cancer. The technology could reduce diagnostic delays, lower costs, and provide high-quality medical imaging to more patients worldwide.

This research investigates a medicinal plant as a potential treatment for prostate cancer and benign prostatic hyperplasia. Findings show reduced PSA levels, hormone regulation, and selective killing of cancer cells while sparing healthy cells. The work suggests a promising, lower-side-effect alternative to conventional therapies, improving outcomes and quality of life.